AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ONC
  4. [Form 4] BeOne Medicines Ltd. American Insider Trading Activity

[Form 4] BeOne Medicines Ltd. American Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Filing content is currently unavailable.

Source:

Stock ONC logo
Beigene Ltd

NASDAQ:ONC

ONC Rankings

#367 Ranked by Market Cap
N/A Ranked by Dividends

ONC Latest News

Aug 21, 2025
European Commission Approves Tablet Formulation of BeOne Medicines� BRUKINSA® for All Approved Indications
Aug 6, 2025
BeOne Medicines Announces Second Quarter 2025 Financial Results and Business Updates
Jul 31, 2025
BeOne Medicines Receives PRIME Designation from the European Medicines Agency for BGB-16673 in Waldenstrom’s Macroglobulinemia
Jul 28, 2025
BeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA® in Neoadjuvant/Adjuvant NSCLC Treatment
Jul 16, 2025
BeOne Medicines to Announce Second Quarter 2025 Financial Results on August 6

ONC Latest SEC Filings

Aug 15, 2025
[Form 4] BeOne Medicines Ltd. American Insider Trading Activity
Aug 15, 2025
[Form 4] BeOne Medicines Ltd. American Insider Trading Activity
Aug 13, 2025
[144] BeOne Medicines Ltd. American SEC Filing
Aug 13, 2025
[144] BeOne Medicines Ltd. American SEC Filing
Aug 6, 2025
[10-Q] BeOne Medicines Ltd. American Quarterly Earnings Report

ONC Stock Data

37.15B
91.06M
17.24%
32.39%
1.64%
Biotechnology
Pharmaceutical Preparations
Switzerland
BASEL